[DISCLOSURE] Hanmi Pharmaceutical (128940) reported on July 27 that its operating profit in the second quarter surged 236.9 percent to 21.55 billion won (US$19.34 million) from the same period last year.

Its revenue fell 5.0 percent to 222.82 billion won and net profit 43.5 percent to 12.07 billion won on-year.

By Hwang You-mee (theinvestor@heraldcorp.com)